Synergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention
Conclusions.The combination of pharmacologic and mechanic antithrombotic treatment during pPCI was associated with better 1‐year clinical outcome. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - Category: Cardiovascular & Thoracic Surgery Authors: Stylianos A. Pyxaras, Fabio Mangiacapra, Katia Verhamme, Luigi Di Serafino, Frederic De Vroey, Gabor Toth, Andrea Perkan, Alessandro Salvi, Jozef Bartunek, Bernard De Bruyne, William Wijns, Gianfranco Sinagra, Emanuele Barbato Tags: Original Study Source Type: research
More News: Abciximab | Angiography | Angioplasty | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Coronary Angioplasty | Heart | Heart Attack | Percutaneous Coronary Intervention | Study | Thrombosis